Assessment of common red blood cell pretreatments to yield an accurate serologic antigen phenotype compared with genotype-predicted phenotype
Horn, T., Hamilton, J., Kosanke, J., Hare, V.W., Kluver, W., Beres, W., Nance, S., Keller, M.A.
Development of red blood cell autoantibodies following treatment with checkpoint inhibitors: a new class of anti-neoplastic, immunotherapeutic agents associated with immune dysregulation
Cooling, L.L.W., Sherbeck, J., Mowers, J.C., Hugan, S.L.
ABO serology in a case of persistent weak A in a recipient following a group O–matched unrelated bone marrow transplant
Grey, D.E., Fong, E.A., Cole, C., Jensen, J., Finlayson, J.
Cover_TOC_Masthead - ISSUE 2/2017
Recognizing and resolving ABO discrepancies
Meny, G.M.
A LU:−16 individual with antibodies
Éthier, C., Parent, C., Lemay, A.-S., Baillargeon, N., Laflamme, G., Lavoie, J., Perreault, J., St-Louis, M.
Use of standard laboratory methods to obviate routine dithiothreitol treatment of blood samples with daratumumab interference
Lintel, N.J., Brown, D.K., Schafer, D.T., Tsimba-Chitsva, F.M., Koepsell, S.A., Shunkwiler, S.M.
Cover_TOC_Masthead - ISSUE 1/2017
Stability guidelines for dithiothreitol-treated red blood cell reagents used for antibody detection methods in patients treated with daratumumab
Disbro, W.L.
Applications of selected cells in immunohematology in a developing country: case studies
Dara, R.C., Tiwari, A.K., Arora, D., Mitra, S., Aggarwal, G., Acharya, D.P., Bhardwaj, G.
Cover_TOC_Masthead - ISSUE 3/2017
The Vel blood group system: a review
Storry, J.R., Peyrard, T.